Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing rate of pet ownership globally
3.2.1.2 Growing advancements in veterinary medicine
3.2.1.3 Rising prevalence of ear infections among pets
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of compliance
3.2.2.2 Side effects of medications
3.3 Growth potential analysis
3.4 Pipeline assessment
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Drug Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Antibiotics
5.2.1 Cephalosporins
5.2.2 Penicillins
5.2.3 Fluoroquinolones
5.2.4 Imidazole
5.2.5 Other antibiotics
5.3 Antifungals
5.4 Corticosteroids
5.5 Cleaning agents
5.6 Other drug types
Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Horses
6.5 Other animal types
Chapter 7 Market Estimates and Forecast, By Medication Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 OTC
7.3 Prescription
Chapter 8 Market Estimates and Forecast, By Mode of Administration, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Otic
8.3 Oral
8.4 Parenteral
8.5 Topical
Chapter 9 Market Estimates and Forecast, By Disease Type, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Otitis externa
9.3 Otitis media
9.4 Otitis interna
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 Veterinary hospital pharmacies
10.3 Drug stores
10.4 Pet specialty stores
10.5 E-commerce
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Bayer AG
12.2 Ceva Sante Animale
12.3 Dechra Pharmaceuticals PLC
12.4 Elanco Animal Health Incorporated
12.5 Entod International
12.6 Merck & Co., Inc.
12.7 Nextmune
12.8 Penn Veterinary Supply, Inc.
12.9 Piedmont Animal Health, Inc.
12.10 Vedco, Inc.
12.11 Vetnique Labs
12.12 Vetoquinol S.A.
12.13 Virbac S.A.
12.14 Wedgewood Village Pharmacy, LLC
12.15 Zoetis Inc.
